Metagenomi is a gene editing company committed to developing potentially curative therapeutics by leveraging a proprietary toolbox of next-generation gene editing systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms.
Market
Therapeutics
Location
Emeryville,
California,
USA
Coinvestors
Deep Track Capital, Eventide Asset Management, Farallon Capital Management, Frazier Healthcare Partners, Humboldt Fund, Marshall Wace, Millennium Management, PFM Health Sciences, Pura Vida Investments, RA Capital Management, Surveyor Capital